Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS).
L PerreaultQ PanV R ArodaE Barrett-ConnorD DabeleaS Dagogo-JackR F HammanS E KahnK J MatherW C KnowlerAshley H TjadenPublished in: Diabetic medicine : a journal of the British Diabetic Association (2017)
Several formerly unexplored factors in the DPPOS predicted additional risk for diabetes and/or microvascular disease - particularly hypertension and the use of anti-hypertensive medications - helping to explain some of the residual disease risk in participants of the DPPOS.